These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9747816)

  • 1. Neoadjuvant chemotherapy and hyperfractionated radiotherapy with concurrent low-dose chemotherapy for squamous cell esophageal carcinoma.
    Raoul JL; Le Prisé E; Meunier B; Heresbach D; Campion JP; Launois B
    Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):29-34. PubMed ID: 9747816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neoadjuvant treatment in surgery of esophageal cancer].
    Launois B; Raoul JL; Leprise E; Meunier B
    Bull Acad Natl Med; 2000; 184(8):1703-13; discussion 1714. PubMed ID: 11471389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant concurrent chemoradiotherapy followed by definitive high-dose radiotherapy or surgery for operable thoracic esophageal carcinoma.
    Murakami M; Kuroda Y; Okamoto Y; Kono K; Yoden E; Kusumi F; Hajiro K; Matsusue S; Takeda H
    Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1049-59. PubMed ID: 9539559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mature survival results with preoperative cisplatin, protracted infusion 5-fluorouracil, and 44-Gy radiotherapy for esophageal cancer.
    Kleinberg L; Knisely JP; Heitmiller R; Zahurak M; Salem R; Burtness B; Heath EI; Forastiere AA
    Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):328-34. PubMed ID: 12738305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Final report of Intergroup Trial 0122 (ECOG PE-289, RTOG 90-12): Phase II trial of neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagus.
    Minsky BD; Neuberg D; Kelsen DP; Pisansky TM; Ginsberg RJ; Pajak T; Salter M; Benson AB
    Int J Radiat Oncol Biol Phys; 1999 Feb; 43(3):517-23. PubMed ID: 10078631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG)/Japan Clinical Oncology Group trial (JCOG9516).
    Ishida K; Ando N; Yamamoto S; Ide H; Shinoda M
    Jpn J Clin Oncol; 2004 Oct; 34(10):615-9. PubMed ID: 15591460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Twice-daily radiotherapy as concurrent boost technique during two chemotherapy cycles in neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: mature results of phase II study.
    Choi N; Park SD; Lynch T; Wright C; Ancukiewicz M; Wain J; Donahue D; Mathisen D
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):111-22. PubMed ID: 15337546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II study of cisplatin, 5-fluorouracil, and leucovorin in inoperable squamous cell carcinoma of the esophagus. ONCOPAZ Cooperative Group, Spain.
    Feliu J; González Barón M; García Girón C; Espinosa E; Vicent JM; Gómez Navarro J; Berrocal A; Ordóñez A; Vilches Y; de Castro J; Díaz J
    Am J Clin Oncol; 1996 Dec; 19(6):577-80. PubMed ID: 8931675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II study of preoperative paclitaxel/cisplatin with radiotherapy in locally advanced esophageal cancer.
    Kim DW; Blanke CD; Wu H; Shyr Y; Berlin J; Beauchamp RD; Chakravarthy B
    Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):397-404. PubMed ID: 17097833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative low-dose weekly cisplatin and continuous infusion fluorouracil plus hyperfractionated radiotherapy in stage II-III esophageal carcinoma.
    Caro M; Font A; Comas S; Viciano M; Remon J; Céliz P; Robles J; Musulén E; Sendrós MJ; Mesalles E; Jiménez JA; Boix J; Arellano A; Fernández-Llamazares J
    Clin Transl Oncol; 2016 Nov; 18(11):1106-1113. PubMed ID: 26856597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant chemotherapy with cisplatinum/5-fluorouracil/low-dose leucovorin for advanced squamous cell carcinoma of the esophagus.
    Ide H; Nakamura T; Hayashi K; Eguchi R; Tanigawa K; Ota M
    Semin Surg Oncol; 1997; 13(4):263-9. PubMed ID: 9229414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerated hyperfractionated radiation therapy and concurrent 5-fluorouracil/cisplatin chemotherapy for locoregional squamous cell carcinoma of the thoracic esophagus: a phase II study.
    Jeremic B; Shibamoto Y; Acimovic L; Matovic Z; Milicic B; Milisavljevic S; Nikolic N
    Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1061-6. PubMed ID: 9539560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ten-year survival with chemotherapy and radiotherapy in patients with squamous cell carcinoma of the esophagus.
    Bidoli P; Bajetta E; Stani SC; De CD; Santoro A; Valente M; Zucali R; Valagussa P; Ravasi G; Bonadonna G
    Cancer; 2002 Jan; 94(2):352-61. PubMed ID: 11900221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagus: a preliminary analysis of the phase II intergroup trial 0122.
    Minsky BD; Neuberg D; Kelsen DP; Pisansky TM; Ginsberg R; Benson A
    J Clin Oncol; 1996 Jan; 14(1):149-55. PubMed ID: 8558190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction chemotherapy followed by concurrent chemotherapy and high-dose radiotherapy for locally advanced squamous cell carcinoma of the upper-thoracic and midthoracic esophagus.
    Stuschke M; Stahl M; Wilke H; Walz M; Oldenburg A; Stüben G; Seeber S; Sack H
    Am J Clin Oncol; 2000 Jun; 23(3):233-8. PubMed ID: 10857883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Accelerated hyperfractionated radiotherapy combined with simultaneous chemotherapy in locally advanced pharyngeal and oral carcinomas].
    Stuschke M; Budach V; Dinges S; Jahnke K; Budach W; Heselmann I; Unger A; Stüben G; Sack H
    Strahlenther Onkol; 1994 Dec; 170(12):689-99. PubMed ID: 7817270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiotherapy with high dose rate brachytherapy boost and concomitant chemotherapy for Stages IIB and III esophageal carcinoma: results of a pilot study.
    Calais G; Dorval E; Louisot P; Bourlier P; Klein V; Chapet S; Reynaud-Bougnoux A; Huten N; De Calan L; Aget H; Le Floch O
    Int J Radiat Oncol Biol Phys; 1997 Jul; 38(4):769-75. PubMed ID: 9240645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase I/II study of external beam radiation, brachytherapy and concurrent chemotherapy in localized cancer of the esophagus (RTOG 92-07): preliminary toxicity report.
    Gaspar LE; Qian C; Kocha WI; Coia LR; Herskovic A; Graham M
    Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):593-9. PubMed ID: 9112458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II evaluation of preoperative chemoradiation and postoperative adjuvant chemotherapy for squamous cell and adenocarcinoma of the esophagus.
    Heath EI; Burtness BA; Heitmiller RF; Salem R; Kleinberg L; Knisely JP; Yang SC; Talamini MA; Kaufman HS; Canto MI; Topazian M; Wu TT; Olukayode K; Forastiere AA
    J Clin Oncol; 2000 Feb; 18(4):868-76. PubMed ID: 10673530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of neoadjuvant radiochemotherapy using low-dose fraction cisplatin and 5-fluorouracil in patients with carcinoma of the esophagus.
    Nakano S; Baba M; Natsugoe S; Kusano C; Shimada M; Fukumoto T; Aikou T
    Jpn J Thorac Cardiovasc Surg; 2001 Jan; 49(1):11-6. PubMed ID: 11233236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.